Update on diabetes diagnosis and management.
Identifieur interne : 000467 ( Main/Exploration ); précédent : 000466; suivant : 000468Update on diabetes diagnosis and management.
Auteurs : Carolyn Robertson [États-Unis] ; Andrew Jay Drexler ; Anthony T. VernilloSource :
- Journal of the American Dental Association (1939) [ 0002-8177 ] ; 2003.
Descripteurs français
- KwdFr :
- Animaux (MeSH), Autosurveillance glycémique (MeSH), Cellules souches (MeSH), Diabète (diagnostic), Diabète (sang), Diabète (thérapie), Glycémie (analyse), Glycémie (métabolisme), Humains (MeSH), Hyperglycémie provoquée (MeSH), Hypoglycémiants (usage thérapeutique), Hémoglobine A glycosylée (analyse), Mode de vie (MeSH), Régime pour diabétique (MeSH), Thérapie génétique (MeSH), Transplantation d'ilots de Langerhans (MeSH).
- MESH :
- analyse : Glycémie, Hémoglobine A glycosylée.
- diagnostic : Diabète.
- métabolisme : Glycémie.
- sang : Diabète.
- thérapie : Diabète.
- usage thérapeutique : Hypoglycémiants.
- Animaux, Autosurveillance glycémique, Cellules souches, Humains, Hyperglycémie provoquée, Mode de vie, Régime pour diabétique, Thérapie génétique, Transplantation d'ilots de Langerhans.
English descriptors
- KwdEn :
- Animals (MeSH), Blood Glucose (analysis), Blood Glucose (metabolism), Blood Glucose Self-Monitoring (MeSH), Diabetes Mellitus (blood), Diabetes Mellitus (diagnosis), Diabetes Mellitus (therapy), Diet, Diabetic (MeSH), Genetic Therapy (MeSH), Glucose Tolerance Test (MeSH), Glycated Hemoglobin A (analysis), Humans (MeSH), Hypoglycemic Agents (therapeutic use), Islets of Langerhans Transplantation (MeSH), Life Style (MeSH), Stem Cells (MeSH).
- MESH :
- chemical , analysis : Blood Glucose, Glycated Hemoglobin A.
- chemical , metabolism : Blood Glucose.
- blood : Diabetes Mellitus.
- diagnosis : Diabetes Mellitus.
- chemical , therapeutic use : Hypoglycemic Agents.
- therapy : Diabetes Mellitus.
- Animals, Blood Glucose Self-Monitoring, Diet, Diabetic, Genetic Therapy, Glucose Tolerance Test, Humans, Islets of Langerhans Transplantation, Life Style, Stem Cells.
Abstract
BACKGROUND
The American Diabetes Association has established recommendations for the testing of undiagnosed people. Once diagnosed, those with diabetes must strive to maintain a level of glucose control that results in a metabolism that approaches that of people without diabetes. The dentist also can provide risk-reduction strategies for people prone to develop diabetes, and refer patients with signs and symptoms suggestive of diabetes to physicians.
METHODS
The authors describe criteria for establishing a diagnosis of diabetes and for identifying people at high risk of developing the disease. A combination of approaches in the medical management of type 1 and type 2 diabetes mellitus is presented, along with target outcomes.
RESULTS
Patients with diabetes maintain a glycosylated hemoglobin value of no higher than 7 percent. New therapeutic research includes early clinical trials of islet cell transplantation and therapeutic cloning from human stem cells, which may provide an alternate source of insulin-producing islet cells and, thus, may offer a potential cure for diabetes.
CONCLUSIONS
Rigorous metabolic control of diabetes can be achieved through a combination of therapeutic modalities and the establishment and maintenance of target outcomes. The dentist can implement preventive strategies and refer patients with signs and symptoms suggestive of diabetes to physicians.
CLINICAL IMPLICATIONS
The dentist and physician must work together as a team to achieve rigorous metabolic control of diabetes in their patients.
DOI: 10.14219/jada.archive.2003.0368
PubMed: 18196669
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Update on diabetes diagnosis and management.</title><author><name sortKey="Robertson, Carolyn" sort="Robertson, Carolyn" uniqKey="Robertson C" first="Carolyn" last="Robertson">Carolyn Robertson</name><affiliation wicri:level="2"><nlm:affiliation>New York Diabetes Program, New York, NY 10016, USA. nydiabetes@aol.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>New York Diabetes Program, New York, NY 10016</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Drexler, Andrew Jay" sort="Drexler, Andrew Jay" uniqKey="Drexler A" first="Andrew Jay" last="Drexler">Andrew Jay Drexler</name></author><author><name sortKey="Vernillo, Anthony T" sort="Vernillo, Anthony T" uniqKey="Vernillo A" first="Anthony T" last="Vernillo">Anthony T. Vernillo</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:18196669</idno><idno type="pmid">18196669</idno><idno type="doi">10.14219/jada.archive.2003.0368</idno><idno type="wicri:Area/Main/Corpus">000398</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000398</idno><idno type="wicri:Area/Main/Curation">000398</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000398</idno><idno type="wicri:Area/Main/Exploration">000398</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Update on diabetes diagnosis and management.</title><author><name sortKey="Robertson, Carolyn" sort="Robertson, Carolyn" uniqKey="Robertson C" first="Carolyn" last="Robertson">Carolyn Robertson</name><affiliation wicri:level="2"><nlm:affiliation>New York Diabetes Program, New York, NY 10016, USA. nydiabetes@aol.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>New York Diabetes Program, New York, NY 10016</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Drexler, Andrew Jay" sort="Drexler, Andrew Jay" uniqKey="Drexler A" first="Andrew Jay" last="Drexler">Andrew Jay Drexler</name></author><author><name sortKey="Vernillo, Anthony T" sort="Vernillo, Anthony T" uniqKey="Vernillo A" first="Anthony T" last="Vernillo">Anthony T. Vernillo</name></author></analytic><series><title level="j">Journal of the American Dental Association (1939)</title><idno type="ISSN">0002-8177</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals (MeSH)</term><term>Blood Glucose (analysis)</term><term>Blood Glucose (metabolism)</term><term>Blood Glucose Self-Monitoring (MeSH)</term><term>Diabetes Mellitus (blood)</term><term>Diabetes Mellitus (diagnosis)</term><term>Diabetes Mellitus (therapy)</term><term>Diet, Diabetic (MeSH)</term><term>Genetic Therapy (MeSH)</term><term>Glucose Tolerance Test (MeSH)</term><term>Glycated Hemoglobin A (analysis)</term><term>Humans (MeSH)</term><term>Hypoglycemic Agents (therapeutic use)</term><term>Islets of Langerhans Transplantation (MeSH)</term><term>Life Style (MeSH)</term><term>Stem Cells (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux (MeSH)</term><term>Autosurveillance glycémique (MeSH)</term><term>Cellules souches (MeSH)</term><term>Diabète (diagnostic)</term><term>Diabète (sang)</term><term>Diabète (thérapie)</term><term>Glycémie (analyse)</term><term>Glycémie (métabolisme)</term><term>Humains (MeSH)</term><term>Hyperglycémie provoquée (MeSH)</term><term>Hypoglycémiants (usage thérapeutique)</term><term>Hémoglobine A glycosylée (analyse)</term><term>Mode de vie (MeSH)</term><term>Régime pour diabétique (MeSH)</term><term>Thérapie génétique (MeSH)</term><term>Transplantation d'ilots de Langerhans (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Blood Glucose</term><term>Glycated Hemoglobin A</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Blood Glucose</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Glycémie</term><term>Hémoglobine A glycosylée</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Diabetes Mellitus</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Diabetes Mellitus</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Diabète</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Glycémie</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Diabète</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Hypoglycemic Agents</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Diabetes Mellitus</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Diabète</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Hypoglycémiants</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Blood Glucose Self-Monitoring</term><term>Diet, Diabetic</term><term>Genetic Therapy</term><term>Glucose Tolerance Test</term><term>Humans</term><term>Islets of Langerhans Transplantation</term><term>Life Style</term><term>Stem Cells</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Autosurveillance glycémique</term><term>Cellules souches</term><term>Humains</term><term>Hyperglycémie provoquée</term><term>Mode de vie</term><term>Régime pour diabétique</term><term>Thérapie génétique</term><term>Transplantation d'ilots de Langerhans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>The American Diabetes Association has established recommendations for the testing of undiagnosed people. Once diagnosed, those with diabetes must strive to maintain a level of glucose control that results in a metabolism that approaches that of people without diabetes. The dentist also can provide risk-reduction strategies for people prone to develop diabetes, and refer patients with signs and symptoms suggestive of diabetes to physicians.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>The authors describe criteria for establishing a diagnosis of diabetes and for identifying people at high risk of developing the disease. A combination of approaches in the medical management of type 1 and type 2 diabetes mellitus is presented, along with target outcomes.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Patients with diabetes maintain a glycosylated hemoglobin value of no higher than 7 percent. New therapeutic research includes early clinical trials of islet cell transplantation and therapeutic cloning from human stem cells, which may provide an alternate source of insulin-producing islet cells and, thus, may offer a potential cure for diabetes.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Rigorous metabolic control of diabetes can be achieved through a combination of therapeutic modalities and the establishment and maintenance of target outcomes. The dentist can implement preventive strategies and refer patients with signs and symptoms suggestive of diabetes to physicians.</p></div><div type="abstract" xml:lang="en"><p><b>CLINICAL IMPLICATIONS</b></p><p>The dentist and physician must work together as a team to achieve rigorous metabolic control of diabetes in their patients.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18196669</PMID><DateCompleted><Year>2008</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-8177</ISSN><JournalIssue CitedMedium="Print"><Volume>134 Spec No</Volume><PubDate><Year>2003</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of the American Dental Association (1939)</Title><ISOAbbreviation>J Am Dent Assoc</ISOAbbreviation></Journal><ArticleTitle>Update on diabetes diagnosis and management.</ArticleTitle><Pagination><MedlinePgn>16S-23S</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The American Diabetes Association has established recommendations for the testing of undiagnosed people. Once diagnosed, those with diabetes must strive to maintain a level of glucose control that results in a metabolism that approaches that of people without diabetes. The dentist also can provide risk-reduction strategies for people prone to develop diabetes, and refer patients with signs and symptoms suggestive of diabetes to physicians.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The authors describe criteria for establishing a diagnosis of diabetes and for identifying people at high risk of developing the disease. A combination of approaches in the medical management of type 1 and type 2 diabetes mellitus is presented, along with target outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with diabetes maintain a glycosylated hemoglobin value of no higher than 7 percent. New therapeutic research includes early clinical trials of islet cell transplantation and therapeutic cloning from human stem cells, which may provide an alternate source of insulin-producing islet cells and, thus, may offer a potential cure for diabetes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Rigorous metabolic control of diabetes can be achieved through a combination of therapeutic modalities and the establishment and maintenance of target outcomes. The dentist can implement preventive strategies and refer patients with signs and symptoms suggestive of diabetes to physicians.</AbstractText><AbstractText Label="CLINICAL IMPLICATIONS" NlmCategory="CONCLUSIONS">The dentist and physician must work together as a team to achieve rigorous metabolic control of diabetes in their patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>New York Diabetes Program, New York, NY 10016, USA. nydiabetes@aol.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drexler</LastName><ForeName>Andrew Jay</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Vernillo</LastName><ForeName>Anthony T</ForeName><Initials>AT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Dent Assoc</MedlineTA><NlmUniqueID>7503060</NlmUniqueID><ISSNLinking>0002-8177</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003927" MajorTopicYN="N">Diet, Diabetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005951" MajorTopicYN="N">Glucose Tolerance Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016381" MajorTopicYN="N">Islets of Langerhans Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>36</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>1</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>1</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>1</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18196669</ArticleId><ArticleId IdType="pii">S0002-8177(14)65195-3</ArticleId><ArticleId IdType="doi">10.14219/jada.archive.2003.0368</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><noCountry><name sortKey="Drexler, Andrew Jay" sort="Drexler, Andrew Jay" uniqKey="Drexler A" first="Andrew Jay" last="Drexler">Andrew Jay Drexler</name><name sortKey="Vernillo, Anthony T" sort="Vernillo, Anthony T" uniqKey="Vernillo A" first="Anthony T" last="Vernillo">Anthony T. Vernillo</name></noCountry><country name="États-Unis"><region name="État de New York"><name sortKey="Robertson, Carolyn" sort="Robertson, Carolyn" uniqKey="Robertson C" first="Carolyn" last="Robertson">Carolyn Robertson</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000467 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000467 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:18196669
|texte= Update on diabetes diagnosis and management.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18196669" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |